ADvTECH : Dealings in securities by Directors, Director of a major subsidiary, prescribed officers and Group Company Secretary

ADvTECH Limited

(Incorporated in the Republic of South Africa) (Registration number 1990/001119/06)

Share code: ADH ISIN: ZAE000031035 ("ADvTECH" or "the Company")

DEALINGS IN SECURITIES BY DIRECTORS, A DIRECTOR OF A MAJOR SUBSIDIARY, PRESCRIBED OFFICERS AND GROUP COMPANY SECRETARY

In terms of paragraphs 3.63 to 3.74 of the JSE Limited Listings Requirements ("JSE Listings Requirements"), the following transactions, in respect of which prior written approval pursuant to paragraph 3.66 of the JSE Listings Requirements have been obtained, is hereby disclosed.

Name of Director:	RJ Douglas
Designation:	Chief Executive Officer
Nature of transaction:	Off-Market acceptance of shares by participants
	to be obtained at future vested periods in terms
	of the ADvTECH Limited Management Share
	Incentive Scheme (MSI).
Number of securities:	285 610
Date of Award	14 June 2022
Class of securities:	Ordinary
Price of share:	R17.89
Total value of transaction:	R5 109 562.90
Date of transaction:	27 June 2022
Nature of interest:	Direct beneficial
Name of Director:	JDR Oesch
Designation:	Group Commercial Director
Nature of transaction:	Off-Market acceptance of shares by participants
	to be obtained at future vested periods in terms
	of the ADvTECH Limited Management Share
	Incentive Scheme (MSI).
Number of securities:	171 861
Date of Award	14 June 2022
Class of securities:	Ordinary

Price of share:

Total value of transaction: Date of transaction: Nature of interest:

Name of Officer:

Designation:

Nature of transaction:

Number of securities: Date of Award Class of securities: Price of share:

Total value of transaction: Date of transaction: Nature of interest:

Name of Officer:

Designation:

Nature of transaction:

Number of securities: Date of Award Class of securities: Price of share:

Total value of transaction: Date of transaction: Nature of interest:

R17.89

R3 074 593.29

27 June 2022

Direct beneficial

DL Honey

Prescribed Officer

Off-Market acceptance of shares by participants to be obtained at future vested periods in terms of the ADvTECH Limited Management Share Incentive Scheme (MSI).

174 172

14 June 2022

Ordinary

R17.89

R3 115 937.08

24 June 2022

Direct beneficial

MD Aitken

Prescribed Officer

Off-Market acceptance of shares by participants to be obtained at future vested periods in terms of the ADvTECH Limited Management Share Incentive Scheme (MSI).

146 760

14 June 2022

Ordinary

R17.89

R2 625 536.40

24 June 2022

Direct beneficial

Name of Officer:

Designation:

Nature of transaction:

Number of securities: Date of Award Class of securities: Price of share:

Total value of transaction: Date of transaction: Nature of interest:

Name of Officer:

Designation:

Nature of transaction:

Number of securities: Date of Award Class of securities: Price of share:

Total value of transaction: Date of transaction: Nature of interest:

Name of Officer:

Designation:

Nature of transaction:

L Wiseman

Prescribed Officer

Off-Market acceptance of shares by participants to be obtained at future vested periods in terms of the ADvTECH Limited Management Share Incentive Scheme (MSI).

99 664

14 June 2022

Ordinary

R17.89

R1 782 988.96

24 June 2022

Direct beneficial

SCD Lurie

The Independent Institute of Education (Pty) Ltd (a major subsidiary of ADvTECH)

Off-Market acceptance of shares by participants to be obtained at future vested periods in terms of the ADvTECH Limited Management Share Incentive Scheme (MSI).

67 584

14 June 2022

Ordinary

R17.89

R1 209 077.76

24 June 2022

Direct beneficial

CB Crouse

Group Company Secretary

Off-Market acceptance of shares by participants to be obtained at future vested periods in terms

	of the ADvTECH Limited Management Share
	Incentive Scheme (MSI).
Number of securities:	24	885
Date of Award	14	June 2022
Class of securities:	Ordinary
Price of share:	R17.89
Total value of transaction:	R445 192.65
Date of transaction:	27	June 2022
Nature of interest:	Direct beneficial

The date of vesting is 17 June 2025.

27 June 2022

Johannesburg

Sponsor: Bridge Capital Advisors Proprietary Limited